Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • Strand SI
    The Avadis NGS Team
    • Feb 2011
    • 26

    #1

    Avadis NGS version 1.2 available now!

    Version 1.2 incorporates new features, some bug fixes, and several enhancements, most importantly the following:
    • Differential SNP analysis has been added to the RNA-Seq and DNA-Seq workflows to identify the SNP locations in a pair of samples (such as in matched tumor-normal) that exhibit differential behavior.
    • Insertions discovered during SNP detection are now annotated with a decibel score.
    • Aligned sequence data generated by the PacBio and Ion Torrent platforms can now be imported into Avadis NGS, in addition to the Illumina, SOLiD, and 454 platforms.
    • Import option for continuous data in the wiggle .WIG file format, allowing users to import and visualize data including GC percentage and conservation scores. These tracks have been added to the human annotation data (h18 and hg19 builds) and will be added to the annotations for organisms currently supported by Avadis NGS. Annotations can be updated through the Annotations Manager.
    • The novel gene detection algorithm has been enhanced to make better use of spliced and paired reads. Novel partition predictions are now annotated with conservation scores derived from the conservation continuous data track.
    • The novel gene detection algorithm has been enhanced to make better use of spliced and paired reads. Novel partition predictions are now annotated with conservation scores derived from the conservation continuous data track.
    • Improvements to the determination of length of translocations and zygosity of structural variants (SV) as part of the SV Detection analysis step in the DNA-Seq workflow.
    • Region lists can now be imported from TSV files and region lists of any size are now supported by all operations.
    • The first six scripts in our online Scripts Library can now be accessed directly from the application.


    The full list of enhancements, bug fixes and know issues is available here or through the Help Menu in Avadis NGS.

    All current users of version 1.1.1 will be automatically prompted for a product update the next time Avadis NGS is launched.

    To evaluate this new version request a trial on our website, then go to the Download Installers section and select the appropriate installer for your operating system. For guidance on software installation and activation there are a number of online guides available on our website or you can contact our support team.

    The Avadis NGS Team
    Last edited by Strand SI; 04-17-2011, 10:31 PM.

Latest Articles

Collapse

  • SEQadmin2
    Proteomic Platforms: How to Choose the Right Analytical Strategy to Improve Detection and Clinical Applications
    by SEQadmin2


    Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.

    The systematic characterization of the human proteome has
    ...
    07-20-2026, 11:48 AM
  • SEQadmin2
    Advanced Sequencing Platforms Tackle Neuroscience’s Toughest Genomics Problems
    by SEQadmin2



    Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
    ...
    07-09-2026, 11:10 AM
  • SEQadmin2
    Cancer Drug Resistance: The Lingering Barrier to Rising Survival
    by SEQadmin2



    Cancer survival rates have significantly increased in the last few decades in the United States, reaching a combined 70% 5-year survival rate by 2021. Behind this number, there are years of research to find new therapies, drug targets, and early detection methods. But there is one core challenge that keeps slowing down these advances, and it’s about drug resistance.

    There is no single reason why many patients don’t respond to treatment as expected. Cancer is...
    07-08-2026, 05:17 AM

ad_right_rmr

Collapse

News

Collapse

Topics Statistics Last Post
Started by SEQadmin2, Today, 02:55 AM
0 responses
4 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 07-24-2026, 12:17 PM
0 responses
10 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 07-23-2026, 11:41 AM
0 responses
11 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 07-20-2026, 11:10 AM
0 responses
23 views
0 reactions
Last Post SEQadmin2  
Working...